Airain Ltd’s MacroGenics MGNX Stock Holding History

Airain Ltd’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-25,258	Closed	-$470K	–	975
2017 Q1	$470K	Buy	+25,258	New	+$487K	0.02%	512
2015 Q3	–	Sell	-8,154	Closed	-$310K	–	982
2015 Q2	$310K	Buy	+8,154	New	+$268K	0.02%	652

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Airain Ltd's MGNX Position: Q2 2017 in Review

Airain Ltd sold out of MacroGenics (MGNX) in Q2 2017, closing a stake of 25,258 shares — an estimated $470K sold.

Airain Ltd first reported a position in MGNX in Q2 2015 and held it in 2 quarters. The position peaked at $470K in Q1 2017. 113 funds tracked by Wall St. Rank hold MGNX as of Q2 2017.

Airain Ltd reported no remaining MacroGenics position as of Q2 2017 after selling out during the quarter.
Airain Ltd sold 25,258 MacroGenics shares in Q2 2017, an estimated $470K.
Airain Ltd first reported a position in MacroGenics in Q2 2015 and held it in 2 quarters.
Airain Ltd's MacroGenics position peaked at $470K in Q1 2017.
113 funds tracked by Wall St. Rank held MacroGenics as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.